GlobeNewswire Inc | May 26, 2021 08:00AM EDT

May 26, 2021

PALO ALTO, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announcedthat Vincerxs Chief Business Officer,Stuart Hwang, PhD, will present a corporate overview at the Jefferies Virtual Healthcare Conference, to be held June 1-4, 2021.

Vincerx Presentation DetailsDate: Thursday, June 3, 2021Time: 10:30 AM Eastern TimeWebcast: https://wsw.com/webcast/jeff174/vinc/1854576

The presentation will be webcast live and archived in theInvestorssection of the Companys website.

About Vincerx Pharma, Inc. Vincerx Pharma, Inc.(Vincerx) is a clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. Vincerx has assembled a management team of biopharmaceutical experts with extensive experience in building and operating organizations that develop and deliver innovative medicines to patients. Vincerxs current pipeline is derived from an exclusive license agreement with Bayer and includes a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation platform, which includes next-generation antibody-drug conjugates and innovative small molecule drug conjugates.

Contact Information Bruce MackleLifeSci Advisors, LLC646-889-1200bmackle@lifesciadvisors.com